Consider Endari for Patients on Hydroxyurea Who Still Have Sickle Cell Crises

Endari (en-DAH-ree, L-glutamine) is the first sickle cell treatment to be approved in almost 20 years....

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote